Results 201 to 210 of about 245,125 (261)

Predictive Biomarkers in Metastatic Colorectal Cancer Patients Treated With Bevacizumab: A Turkish Oncology Group (TOG) Study

International Journal of Cancer, EarlyView.
Bevacizumab added to systemic chemotherapy remains a cornerstone of metastatic colorectal cancer treatment, but its effectiveness is variable. Tumors can bypass the VEGF blockade by activating other pro‐angiogenic pathways, hampering the identification of predictive biomarkers.
Büsra Akay Hacan, Fatma Gizem Sonugür, Müge Öçal, Cansu Babahan, Samira Abgarmi, Ülkü Yalçıntaş Arslan, Mehmet Ali Şendur, Ahmet Demirkazık, Güngör Utkan, Hakan Akbulut   +9 more
wiley   +1 more source

Outcomes of anti-VEGF therapy compared with conventional interventions in diabetic retinopathy management. [PDF]

Exp Ther Med
Guo Y, Yang R, Li Y, Guo C, Liang H.
europepmc   +1 more source

Longitudinal Multi-Omics Profiling of Aqueous Humor Implicates GALNS Depletion as a Pro-Fibrotic Mediator of Anti-VEGF Therapy in PDR. [PDF]

Invest Ophthalmol Vis Sci
Huang Y, Gui M, Kong X, Li T, Xu Z, Li J, Xian B, Zhang Y, Zhuang X, Zhang L, Cao D.   +10 more
europepmc   +1 more source

Efficacy of anti-VEGF single-chain variable fragment AAV-based gene therapy in a laser-induced choroidal neovascularisation mouse model. [PDF]

Mol Ther Adv
Salman A, Griffiths H, Garba K, Lynn SA, Cree AJ, Szczepan M, Jashal CB, Chozhavel T M R, Rao P, Modi K, MacLaren RE, Yuen HM, Lotery AJ.   +12 more
europepmc   +1 more source

Psychosocial determinants of anti-VEGF treatment adherence in AMD patients: optimization of one-stop intravitreal injection service model. [PDF]

Front Med (Lausanne)
Zhang X, Cui B, Liu Y, Ji X, Tian X, Hou S, Yang L, Yang J.   +7 more
europepmc   +1 more source

Long-term disease control with anti-VEGF treat-and-extend treatment in macular edema due to retinal vein occlusion. [PDF]

BMC Ophthalmol
Fischer S, Hoffmann L, Hatz K.
europepmc   +1 more source

Evaluation of Spectral Domain OCT Changes Following Anti-VEGF Therapy in Diabetic Macular Edema.

J Pharm Bioallied Sci
Mandloi G, Jain A, Sharma A, Tirkey ER, Jain S.   +4 more
europepmc   +1 more source

ANTI-VEGF TREATMENT Safety of intravitreal anti-VEGFs during pregnancy is unclear

, 2012
Georgalas, Ilias, Petrou, Petros, Koutsandrea, Chrysanthi   +2 more
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Anti-VEGF Treatment of Corneal Neovascularization

Ocular Surface, 2011
Vascular endothelial growth factor (VEGF) is an angiogenic factor shown to be a critical secreted cytokine in tumorigenesis and retinal neovascularization (NV). Currently, there are two anti-VEGF agents, pegaptanib and ranizumab, approved by the United States Food and Drug Administration (FDA) for intravitreal use in the treatment of wet age-related ...
Deborah Jacobs
exaly   +3 more sources